Granules India Ltd.

₹821.75

-24.8 (-2.9%)

GRANULES Share Price

Pharmaceuticals & Biotechnology

As on October 1, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 22,389.8 Cr

P/E Ratio34.22

Dividend Yield0.21 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	851.02	Bearish
10-DMA	858.3	Bearish
20-DMA	865.99	Bearish
50-DMA	853.35	Bearish
100-DMA	826.11	Bearish
200-DMA	717.38	Bullish

Historical Performance

1 Year

51.4%

3 Years

131.6%

5 Years

151.1%

10 Years

606.6%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	53,656	44,816	45,064	45,119	37,649
Total Expenditure	41,805	35,364	36,504	35,986	30,433
Other Income	203	129	44	143	182
Operating Profit	12,055	9,582	8,604	9,276	7,398
Interest	1,144	1,032	1,058	559	232
Depreciation	2,961	2,255	2,073	1,845	1,586
Profit Before Tax	7,850	6,602	5,472	6,872	5,580
Consolidated Net Profit	5,950	5,015	4,053	5,166	4,128
Adjusted EPS	24	21	17	21	17

Compounded Sales Growth

10 Years:31.6

5 Years:10.6

3 Years:3.5

TTM:3.7

Compounded Profit Growth

10 Years:37.1

5 Years:1.6

3 Years:2.9

TTM:3.5

Stock Price CAGR

10 Years:21.6

5 Years:20.2

3 Years:32.3

TTM:51.5

Return on Equity

10 Years:7.2

5 Years:16.6

3 Years:16.7

last year:24

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	248	243	242	242	248
Total Reserves	46,946	36,776	31,830	27,927	25,450
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	4,791	4,660	1,760	2,547	2,828
Other Current Liabilities	3,361	3,046	2,611	1,932	2,009
Short Term Borrowings	10,253	9,226	10,542	8,109	7,656
Total Liabilities	76,561	61,847	54,839	49,031	45,115
Capital Work in Progress	4,065	4,369	2,595	2,280	3,119
Long Term Loans & Advances	2,263	1,795	1,900	1,575	895
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	1,630	1,802	1,860	1,142	1,304
Total Current Assets	37,676	31,155	29,050	25,741	25,050
Total Assets	76,561	61,847	54,839	49,031	45,115
Adjusted Book Value	190	153	132	116	104

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 34.22, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 32.1%, indicating sustained price appreciation.
The stock carries a beta of 0.8, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹12055 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹53656 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1474520

No. of Shares: 1794 (Approx)

Performance:47.5%

474520

NIFTY Performance: -9.7%

1 day Top Gainers